Embera NeuroTherapeutics Completes Series B Financing and Receives Grants to Advance EMB-001 into Phase 2 Clinical Studies in Cocaine Use Disorder and Smoking Cessation

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2sHsdDY
via IFTTT